Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock — 현금 흐름 (NASDAQ:FBIOP)

Financials

영업활동으로 인한 현금 -83.68 M-116.54 M-179.4 M-128.22 M-80.19 M-65.78 M 157.64 M 투자 활동으로 인한 현금 -7.16 M40.51 M-22.93 M-2.1 M-15 M10.12 M 8.96 M 재무활동으로 인한 현금 172.41 M148.99 M75.32 M32.74 M70.64 M77.44 M -2.09 M 잉여 현금 흐름 -83.68 M-116.54 M-179.4 M-128.22 M-80.19 M-65.78 M 157.64 M

Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

FBIOP

Financials

Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

뉴스

포트리스 바이오텍, 멘케스병 치료제 NDA 재신청 보고

Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript

Fortress Biotech, Inc. (FBIO) Q4 2024 Earnings Call Transcript